DeepMed Research

Center for Research in Security Prices, LLC

🇺🇸United States

Country: 🇺🇸United States

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Noninvasive Hemoglobin Monitor in the ER

Not Applicable

Withdrawn

Conditions: Hemoglobin

Interventions: Device: Radical-7 Noninvasive Hgb Monitor

First Posted Date: 2015-04-20

Last Posted Date: 2018-08-27

Lead Sponsor: University of Chicago

Registration Number: NCT02421250

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Bendamustine, Obinutuzumab, and Dexamethasone in Older Patients With Diffuse Large B-cell Lymphoma

Phase 2

Terminated

Conditions: Diffuse Large B-Cell Lymphoma

Interventions: Drug: Bendamustine Hydrochloride
Biological: Obinutuzumab
Drug: Dexamethasone
Other: Quality-of-Life Assessment
Other: Laboratory Biomarker Analysis

First Posted Date: 2015-04-17

Last Posted Date: 2018-06-06

Lead Sponsor: University of Chicago

Target Recruit Count: 2

Registration Number: NCT02420210

Locations: 🇺🇸
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States

Child Protective Outcomes Among Ultra-poor Families in Burkina Faso

Not Applicable

Completed

Conditions: Child Abuse
Child Maltreatment

Interventions: Behavioral: Trickle Up
Behavioral: Trickle Up Plus

First Posted Date: 2015-04-14

Last Posted Date: 2024-12-31

Lead Sponsor: University of Chicago

Target Recruit Count: 720

Registration Number: NCT02415933

Locations: 🇧🇫
Trickle Up Burkina Faso, Ouagadougou, Burkina Faso

Impact of the CommunityRx Program on Health, Service Utilization and Costs

Not Applicable

Completed

Conditions: Connecting Patients to Self-care Resources

Interventions: Behavioral: HealtheRx

First Posted Date: 2015-04-08

Last Posted Date: 2024-05-09

Lead Sponsor: University of Chicago

Target Recruit Count: 113295

Registration Number: NCT02411409

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Use Art-assist and Neupogen to Treat Chronic Limb Ischemia

Phase 4

Withdrawn

Conditions: Lower Limb Ischemia

Interventions: Drug: Neupogen
Device: Art-Assist Device

First Posted Date: 2015-04-06

Last Posted Date: 2016-04-08

Lead Sponsor: University of Chicago

Registration Number: NCT02408991

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis

Phase 4

Completed

Conditions: Allergic Rhinitis

Interventions: Drug: Fluticasone propionate
Drug: Fluticasone/Azelastine nasal spray
Drug: Placebo
Procedure: Nasal Allergen Challenge

First Posted Date: 2015-03-30

Last Posted Date: 2024-10-17

Lead Sponsor: University of Chicago

Target Recruit Count: 22

Registration Number: NCT02402465

Locations: 🇺🇸
The University of Chicago Medicine, Chicago, Illinois, United States

Automated Respiration Rate to Improve Accuracy of the Electronic Cardiac Arrest Risk Triage Score (eCART) Algorithm

Completed

Conditions: Heart Arrest

First Posted Date: 2015-03-26

Last Posted Date: 2016-05-20

Lead Sponsor: University of Chicago

Target Recruit Count: 133

Registration Number: NCT02399930

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

Pembrolizumab in Treating Patients With Malignant Mesothelioma

Phase 2

Active, not recruiting

Conditions: Epithelioid Mesothelioma
Pleural Biphasic Mesothelioma
Recurrent Pleural Malignant Mesothelioma
Pleural Sarcomatoid Mesothelioma
Recurrent Peritoneal Malignant Mesothelioma
Sarcomatoid Mesothelioma
Pleural Epithelioid Mesothelioma
Pleural Malignant Mesothelioma
Biphasic Mesothelioma
Peritoneal Malignant Mesothelioma

Interventions: Biological: Pembrolizumab
Other: Laboratory Biomarker Analysis
Other: Pharmacogenomic Study

First Posted Date: 2015-03-26

Last Posted Date: 2024-05-13

Lead Sponsor: University of Chicago

Target Recruit Count: 65

Registration Number: NCT02399371

Locations: 🇺🇸
University of Chicago, Chicago, Illinois, United States

miPlan: A Trial of miPlan Intervention vs. Standard of Care

Not Applicable

Completed

Conditions: Unintended Pregnancy

Interventions: Behavioral: miPlan intervention

First Posted Date: 2015-03-24

Last Posted Date: 2016-08-25

Lead Sponsor: University of Chicago

Target Recruit Count: 225

Registration Number: NCT02396602

Locations: 🇺🇸
Planned Parenthood Illinois, Englewood Health Center, Chicago, Illinois, United States

Household Air Pollution and Pregnancy Outcome

Not Applicable

Completed

Conditions: Pregnancy

Interventions: Other: Traditional Cookstove
Other: Clean Cookstove

First Posted Date: 2015-03-20

Last Posted Date: 2024-10-16

Lead Sponsor: University of Chicago

Target Recruit Count: 307

Registration Number: NCT02394574

Locations: 🇳🇬
College of Medicine. University of lbadan, Ibadan, Ibadan, Nigeria

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy